More on GILD
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $157.19 |
|
|||
| Open | $156.47 | ||||
| 52 Wk High | $108.63 | ||||
| 52 Wk Low | $71.39 | ||||
| Day High | $157.65 | ||||
| Day Low | $155.76 | ||||
| P/E | 86.21 | ||||
| EPS | $1.81 | ||||
| Volume | 6,070,932 | ||||
- Gilead Sciences (GILD) PT Raised to $185 at Jefferies
- Gilead to buy oral IBD drug candidate for $1.275 billion
- Gilead to Acquire Investigational Oral IL-23R Inhibitor HCXT-2001, Strengthening Its Inflammation Pipeline in IBD
- Gilead to present 21 abstracts on rare liver diseases at AASLD 2026
- Gilead to Present New Data on Treatment Response and Long-Term Management of Rare Liver Diseases at The Liver Meeting® 2026
- Gilead Sciences (GILD) PT Raised to $172 at BofA Securities
- Gilead to present HIV and antiviral data at IDWeek 2026
- Gilead to Present New Data Across HIV and Emerging Antiviral Research at IDWeek 2026
- Form 4 GILEAD SCIENCES, INC. For: Oct 15 Filed by: Dickinson Andrew D
- Form 4 GILEAD SCIENCES, INC. For: Oct 15 Filed by: Mercier Johanna
Entities mentioned with GILD
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- ARK | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Maynard Um | View Related Stories »
- Options | View Related Stories »
- Show More...
